SCHEMBL1084355

SCHEMBL1084355

CCSc1ccc2nc(-c3ccccc3O)nc(N(C)C)c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.45
CYP1A2 P05177 5/20 0.45
CYP2D6 P10635 5/20 0.45
CLK4 Q9HAZ1 2/20 0.45
MAPK1 P28482 2/20 0.45
CYP2C19 P33261 2/20 0.45
KMT2A Q03164 7/20 0.44
MEN1 O00255 6/20 0.44
MAPT P10636 5/20 0.44
ALDH1A1 P00352 3/20 0.44
POLB P06746 2/20 0.44
HPGD P15428 2/20 0.44
LMNA P02545 3/20 0.43
USP2 O75604 2/20 0.43
CYP3A4 P08684 2/20 0.43
TP53 P04637 1/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CHEK2 O96017 2/20 0.42
CYP2C9 P11712 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1084425 0.80 TSHR (0.55) TSHRCYP1A2CYP2D6CLK4MAPK1
SCHEMBL1084142 0.80 TSHR (0.48) TSHRCYP1A2CYP2D6CLK4MAPK1
SCHEMBL1084870 0.79 TSHR (0.50) TSHRCYP1A2CYP2D6CLK4MAPK1
SCHEMBL1084152 0.79 TSHR (0.53) TSHRCYP1A2CYP2D6CLK4MAPK1
SCHEMBL1084217 0.79 CYP2D6 (0.50) TSHRCYP1A2CYP2D6CLK4MAPK1
SCHEMBL1083919 0.79 TSHR (0.56) TSHRCYP1A2CYP2D6CLK4MAPK1
SCHEMBL1083829 0.78 CYP2D6 (0.70) TSHRCYP1A2CYP2D6CLK4MAPK1
SCHEMBL1084413 0.78 CYP2D6 (0.49) TSHRCYP1A2CYP2D6CLK4MAPK1
SCHEMBL939041 0.77 CYP1A2 (0.54) TSHRCYP1A2CYP2D6CLK4MAPK1
SCHEMBL1084198 0.77 CYP1A2 (0.48) TSHRCYP1A2CYP2D6CLK4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed